Patient-important outcomes in registered diabetes trials.
about
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsPatient involvement in clinical research: why, when, and howA systematic review of approaches for engaging patients for research on rare diseasesWhat matters to children with CFS/ME? A conceptual model as the first stage in developing a PROMOutcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activityDesigning and evaluating an interprofessional shared decision-making and goal-setting decision aid for patients with diabetes in clinical care--systematic decision aid development and study protocol.Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies.Practice network-based care management for patients with type 2 diabetes and multiple comorbidities (GEDIMAplus): study protocol for a randomized controlled trial.A systematic review of the processes used to link clinical trial registrations to their published resultsFatigue in patients with diabetes: a reviewThe association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.Outcomes in registered, ongoing randomized controlled trials of patient education.Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability.Patient-centered medicine and patient-oriented research: improving health outcomes for individual patientsDevelopment of a core set of outcomes for randomized controlled trials with multiple outcomes--example of pulp treatments of primary teeth for extensive decay in childrenStudy design and quality of reporting of randomized controlled trials of chronic idiopathic or autoimmune urticaria: reviewTowards patient-oriented diabetes care: results from two KORA surveys in southern Germany.Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set.Better prioritization to increase research value and decrease waste.Impact of an interprofessional shared decision-making and goal-setting decision aid for patients with diabetes on decisional conflict--study protocol for a randomized controlled trial.Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.Treatment of hyperprolactinemia: a systematic review and meta-analysis.Increasing value and reducing waste in research design, conduct, and analysisHow patients with type 2 diabetes mellitus respond to motivational interviewingExclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details.The Irish DAFNE study protocol: a cluster randomised trial of group versus individual follow-up after structured education for type 1 diabetes.From evidence to practice: consensus in cardiovascular risk assessment and diabetes.A core outcome set for evaluating self-management interventions in people with comorbid diabetes and severe mental illness: study protocol for a modified Delphi study and systematic reviewPatient-important outcomes in randomized controlled trials in critically ill patients: a systematic review.A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.Are outcomes reported in surgical randomized trials patient-important? A systematic review and meta-analysis.Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review.Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.Patient-reported outcomes in meta-analyses--Part 1: assessing risk of bias and combining outcomes.Composite scores in comparative effectiveness research: counterbalancing parsimony and dimensionality in patient-reported outcomes.Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.Guidelines for reporting meta-epidemiological methodology research.
P2860
Q21144611-C6F1DCB0-E434-4544-97B7-20E0818A607AQ22241288-7F2A90EA-0E71-403B-93EA-6577F5F06CE2Q24628988-B90C9BD8-5C12-4AE8-88D4-67AFAB6387F8Q26750036-19001F88-5D8F-4C95-A148-E0D842F849F2Q26822274-0E1DE10B-0CD0-434C-A93F-AB11C82A5DE8Q27320499-5F95F25B-EF82-43FB-9CDE-8BC958501DE6Q28475775-99E95A3B-1786-4142-BF67-EEC60BB245F9Q30573016-14258DF8-5A75-4502-AC37-92AE19C31AB3Q33808742-4528A084-CE58-4994-92C3-EEBA1ABA6025Q33847318-07610618-CB7C-408E-A224-924529C657D1Q33864361-96649D31-AED3-4585-B11B-F5A00646D994Q34000723-CFACED86-0E85-45FA-B23F-571EEC4F5910Q34215047-777FDB0C-7FD5-493D-A272-213FA3E4557AQ34391137-4ACCFD6C-5B48-4BCD-B55C-FC4DE3658FA4Q34437529-5479E899-6876-41CB-ACB5-592E3937B3B5Q34538048-9B8A8BEF-ADC7-433B-A6F1-D22139DE049DQ34542034-9DB9DBC1-6033-47CE-BB9E-D6AC6839196CQ34935840-F3702FEA-FE8F-4B4C-9655-FF4B67AA7258Q35240017-DB4B7B37-9F66-43A6-BA27-25A58E00145FQ35535771-8BCF7E07-3457-4FDD-9860-6C308A956902Q35791171-8009D7DA-FFB4-4103-83E0-61761E946F97Q35800548-8152A448-9DED-4B7C-8EF5-C1A788490D44Q35977529-BEAE304A-BE9C-45C6-8053-98B41C96D2B4Q36329179-93B105B4-2ED5-4623-84A1-1540C8CAAA28Q36355322-8F999A9D-ACAB-4E41-A3F1-8C45A78201D6Q36420861-7695F0D0-D456-4A25-8D09-9BDEB234219CQ36940136-E30F8E7E-3932-41F7-8C32-88DEBF98404FQ37312569-E0355713-5823-40F4-8719-60892383326AQ37387448-865994F2-125E-4724-A6D6-9EA79DCD13A6Q37470277-04E15BF0-85D5-4608-AEF2-CB8A7D97CE0DQ37642902-2DD10169-9F49-409F-A870-A8241CDA7B25Q37685427-FE219B4A-AA3F-4F41-BEEB-135EC85907E6Q37696559-959704EE-3A20-4CEB-9A6D-009C4B83CF91Q37730441-590BA363-5F4D-4649-B0C6-C666BA2580D3Q37805903-828E9C30-19E4-433C-B16F-0F18D52AA999Q37876787-1C967CB5-E2B4-4C2E-BC96-4ECC4898BB9FQ38118394-A7BB5BB6-7A51-4E5D-B3E5-B647E124FB1DQ38256058-5BDCC14D-BE94-4EBD-BEE6-DB5ADFD69C7DQ38386958-CAE43BCC-2FF5-4688-83AE-796FE24628B5Q39431249-429272FA-88AB-4C49-9140-A2C939E10011
P2860
Patient-important outcomes in registered diabetes trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Patient-important outcomes in registered diabetes trials.
@en
type
label
Patient-important outcomes in registered diabetes trials.
@en
prefLabel
Patient-important outcomes in registered diabetes trials.
@en
P2093
P50
P356
P1476
Patient-important outcomes in registered diabetes trials.
@en
P2093
Brian A Swiglo
David N Flynn
Gunjan Y Gandhi
Mohamed B Elamin
Rebecca J Mullan
William L Isley
P304
P356
10.1001/JAMA.299.21.2543
P407
P577
2008-06-01T00:00:00Z